Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Impact of mammographic screening is not clear
| The first 150 words of the full text of this article appear below. |
EDITOR
We should all rejoice that there has been an improvement in
survival and reduction in mortality for carcinoma of the breast, but
Richards et al in their paper perpetuate the myth that this is related
to the breast screening programme.1 The periods for
comparison were 1981-5 and 1986-90.
The Forrest report on mammographic screening was published in
1986,2 the first screening centres were established in
1988, and the country was not covered by the programme until 1990. Even the greatest zealots for mammographic screening would not expect an
impact on mortality until 1997. The fall in mortality could therefore
be attributed only to improvements in treatment, and it is relevant to
note that the first overview of the trials of adjuvant systemic
treatment were published in 1985.3 The only support for
the assertion that the reduction in mortality can be attributed to the
breast screening programme was a personal communication from